Clarivate Integrates Regulatory Intelligence with Claude AI for Biopharma and Medtech Industries
Clarivate Plc announced the integration of its Cortellis Regulatory Intelligence with Anthropic's Claude AI, providing biopharma and clinical research organizations with context-aware regulatory data access within existing AI workflows. This integration aims to enhance regulatory decision-making by embedding authoritative content directly into customer workflows, allowing for improved monitoring and decision support. The initiative is part of Clarivate's strategy to extend its intelligence into AI ecosystems.
Theia Market Signal Identification - AI Assisted
Clarivate Plc is integrating its Cortellis Regulatory Intelligence (CRI) with Anthropic's Claude AI to facilitate access to regulatory data for biopharma and medtech organizations. This integration employs the Model Context Protocol (MCP) to embed regulatory content within existing AI workflows, enhancing decision-making with accurate data.
The partnership aims to extend Clarivate's intelligence into AI environments, allowing customers to build agents that combine CRI with internal data. This move follows the launch of the CRI AI Assistant, further advancing automation across regulatory workflows.
Comments